Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ACC 2015: Edwards, Medtronic lock horns with positive next-gen TAVI data

This article was originally published in Clinica

Executive Summary

The rivalry between the two leading firms in the transcatheter aortic valve implantation (TAVI) market, Edwards Lifesciences and Medtronic, looks set to continue, with both reporting positive results with their next-generation devices. The data were presented at the American College of Cardiology (ACC) meeting, being held in San Diego, California on 14-16 March.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts